Many cancers drive tryptophan consumption [102] and it has been shown that the primary product of tryptophan metabolism, kynurenine, is an endogenous ligand for the aryl hydrocarbon receptor, which mediates invasive tumor growth and the evasion of immunity [102,103,104]. The gene discussed is AHR; the disease is neoplasm.